ouabain has been researched along with Infections, Coronavirus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D | 1 |
| El-Kersh, DM; Islam, MT; Jamaddar, S; Mubarak, MS; Sarkar, C; Shilpi, JA; Uddin, SJ | 1 |
1 review(s) available for ouabain and Infections, Coronavirus
| Article | Year |
|---|---|
Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.
Topics: Alkaloids; Animals; Antiviral Agents; Biological Products; Coronavirus; Coronavirus Infections; Drug Development; Humans; Indolizines; Ouabain; Phenanthrenes; Plant Extracts; Quinolizines; Triterpenes; Viral Proteins; Virus Replication | 2020 |
1 other study(ies) available for ouabain and Infections, Coronavirus
| Article | Year |
|---|---|
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells | 2020 |